Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy.

被引：0
|
作者：
Miyamoto, David Tomoaki
Gibb, Ewan
Mouw, Kent William
Liu, Yang
Wu, Chin-Lee
Drumm, Michael
Lehrer, Jonathan
Ashab, Hussam Al-Deen
Erho, Nicholas
Du Plessis, Marguerite
Ong, Kaye
Shipley, William U.
Davicioni, Elai
Efstathiou, Jason A.
机构：
[1] Massachusetts Gen Hosp Harvard Med Sch, Boston, MA USA
[2] GenomeDx Biosciences Inc, Vancouver, BC, Canada
[3] Dana Farber Canc Inst, Brookline, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.513
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
513
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer
    Nguyen, Eric K.
    Yu, Hang
    Pond, Gregory
    Shayegan, Bobby
    Pinthus, Jehonathan H.
    Kapoor, Anil
    Mukherjee, Som D.
    Neville, Alan
    Lalani, Aly-Khan A.
    Hotte, Sebastien J.
    Corbett, Thomas B.
    Dayes, Ian S.
    Lukka, Himanshu R.
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (04): : 122 - 129
  • [2] Bladder-sparing trimodal therapy for muscle invasive bladder cancer
    Khalifa, J.
    Roumiguie, M.
    Pouessel, D.
    Sargos, P.
    [J]. CANCER RADIOTHERAPIE, 2022, 26 (6-7): : 771 - 778
  • [3] Updated results of bladder-sparing trimodality approach for invasive bladder cancer
    Zapatero, Almudena
    Martin de Vidales, Carmen
    Arellano, Ramon
    Bocardo, Gloria
    Perez, Mar
    Rios, Patricia
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2010, 28 (04) : 368 - 374
  • [4] Trimodality bladder-sparing approach versus radical cystectomy for invasive bladder cancer
    AlGizawy, Samy M.
    Essa, Hoda H.
    Abdel-Wanis, Mostafa E.
    Raheem, Ahmed M. Abdel
    [J]. JOURNAL OF RADIOTHERAPY IN PRACTICE, 2014, 13 (04) : 428 - 437
  • [5] Genomic profiling of muscle invasive bladder cancer to predict response to chemoradiation therapy
    Miyamoto, D.
    Gibb, E.
    Mouw, K.
    Liu, Y.
    Wu, C.
    Drumm, M.
    Lehrer, J.
    Ashab, H.
    Erho, N.
    Du Plessis, M.
    Ong, K.
    Shipley, W.
    Davicioni, E.
    Efstathiou, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S21 - S21
  • [6] Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Efstathiou, Jason A.
    Mouw, Kent W.
    Gibb, Ewan A.
    Liu, Yang
    Wu, Chin-Lee
    Drumm, Michael R.
    da Costa, Jose Batista
    du Plessis, Marguerite
    Wang, Natalie Q.
    Davicioni, Elai
    Feng, Felix Y.
    Seiler, Roland
    Black, Peter C.
    Shipley, William U.
    Miyamoto, David T.
    [J]. EUROPEAN UROLOGY, 2019, 76 (01) : 59 - 68
  • [7] The efficacy of trimodality bladder-sparing treatment in bladder cancer
    Liebman, M. C.
    Wu, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Elective Bladder-Sparing Treatment for Muscle Invasive Bladder Cancer
    Lendinez-Cano, G.
    Rico-Lopez, J.
    Moreno, S.
    Fernandez Parra, E.
    Gonzalez-Almeida, C.
    Camacho Martinez, E.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2014, 38 (01): : 7 - 13
  • [9] Genomic Determinants of Response to Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Kamran, S. C.
    Zhou, Y.
    Otani, K.
    Drumm, M. R.
    Otani, Y.
    Wu, S.
    Wu, C. L.
    Borger, D.
    Lennerz, J. K.
    Van Allen, E. M.
    Willers, H.
    Hong, T. S.
    Liu, Y.
    Davicioni, E.
    Gibb, E.
    Shipley, W. U.
    Mouw, K. W.
    Efstathiou, J. A.
    Miyamoto, D. T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S24 - S24
  • [10] Re: Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-sparing Trimodality Therapy for Muscle-invasive Bladder Cancer
    Narayan, Vikram M.
    Lim, Amy H.
    Dinney, Colin P. N.
    [J]. EUROPEAN UROLOGY, 2019, 75 (06) : 1034 - 1035
12345